Headlines about Biogen (NASDAQ:BIIB) have been trending somewhat positive this week, AlphaOne Sentiment Analysis reports. The research firm, a subsidiary of Accern, identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores […]
